Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Defibrillators industry 3600 synopsis, 2018-2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 End-use trends
2.1.4 Regional trends
Chapter 3 Defibrillators Industry Insights
3.1 Industry landscape
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of cardiac diseases
3.2.1.2 Technological advancements and introduction of innovative devices
3.2.1.3 Increasing public awareness
3.2.1.4 Increasing demand for wearable cardioverter defibrillators
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of the devices
3.2.2.2 Product recalls
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By end use
3.4 COVID- 19 impact analysis
3.5 Pricing analysis, by region, 2022
3.5.1 North America
3.5.2 Europe
3.5.3 Asia Pacific
3.5.4 Latin America
3.5.5 MEA
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Reimbursement scenario
3.7.1 Implantable cardioverter defibrillators (ICDs)
3.7.2 Automatic External Defibrillators (AEDs)
3.8 Technology landscape
3.9 Pipeline products
3.10 Indication landscape
3.10.1 Implantable cardioverter defibrillators (ICDs)
3.10.2 Wearable external cardioverter defibrillators (WCDs)
3.11 Startup scenario
3.12 Porter's analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Global company market share analysis, 2021
4.4 Strategy dashboard, 2021
Chapter 5 Defibrillators Market, By Product
5.1 Key product trends
5.2 Implantable Cardioverter Defibrillator (ICDs)
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Market estimates and forecast, 2018 - 2032 (Units)
5.2.3 Subcutaneous implantable cardioverter defibrillator
5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.3.2 Market estimates and forecast, 2018 - 2032 (Units)
5.2.4 Transvenous implantable cardioverter defibrillator
5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.4.2 Market estimates and forecast, 2018 - 2032 (Units)
5.2.4.3 Single-chamber ICDs
5.2.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.4.3.2 Market estimates and forecast, 2018 - 2032 (Units)
5.2.4.4 Dual-chamber ICDs
5.2.4.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.4.4.2 Market estimates and forecast, 2018 - 2032 (Units)
5.3 External cardioverter defibrillator
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Market estimates and forecast, 2018 - 2032 (Units)
5.3.3 Manual external defibrillator
5.3.3.1.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3.1.2 Market estimates and forecast, 2018 - 2032 (Units)
5.3.4 Automated external defibrillator
5.3.4.1.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.4.1.2 Market estimates and forecast, 2018 - 2032 (Units)
5.3.4.2 Semi-automated external defibrillator
5.3.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.4.2.2 Market estimates and forecast, 2018 - 2032 (Units)
5.3.4.3 Fully automated external defibrillator
5.3.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.4.3.2 Market estimates and forecast, 2018 - 2032 (Units)
5.3.5 Wearable external cardioverter defibrillator
5.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.5.2 Market estimates and forecast, 2018 - 2032 (Units)
Chapter 6 Defibrillators Market, By End-use
6.1 Key end-use trends
6.2 Hospitals
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Ambulatory surgical centers
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Others
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Defibrillators Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Poland
7.3.7 The Netherlands
7.3.8 Sweden
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Indonesia
7.4.7 Thailand
7.4.8 Malaysia
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Chile
7.5.5 Columbia
7.5.6 Peru
7.6 MEA
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Israel
7.6.5 Iran
7.6.6 Turkey
Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc.
8.2 AMI Italia
8.3 BIOTRONIK SE & Co. KG
8.4 Boston Scientific Corporation
8.5 CU Medical Systems Co. Ltd
8.6 Koninkilijke Philips N.V.
8.7 Medtronic plc
8.8 Meditech Equipment Co., Ltd (Meditech Group)
8.9 MicroPort Scientific Corporation
8.10 Mindray Medical International Limited
8.11 Nihon Kohden Corporation
8.12 BPL Medical Technologies Pvt Ltd
8.13 Schiller AG
8.14 Stryker Corporation
8.15 ZOLL Medical Corporation (Asahi Kasei Group)
